{"schema_version":"1","generated_at":"2026-11-10T12:42:47.813Z","data_as_of":null,"url":"https://www.findmykol.com/kol/dana-angelini","json_url":"https://www.findmykol.com/kol/dana-angelini/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"dana-angelini","name":"Dana Angelini","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cleveland Clinic","institution_url":"https://www.findmykol.com/institution/cleveland-clinic","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1114160462","orcid":"0000-0002-2801-9737","openalex":"A5037531240"},"summary":"Dana Angelini is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 77 publications with 1,348 citations (h-index 17).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":77,"cited_by_count":1348,"h_index":17,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":7830,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114160462"},{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":3885,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114160462"},{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":2773.89,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114160462"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1114160462","source":"payments"},"prescribing":{"data_year":2023,"areas_total":4,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":67,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":59.3,"drugs":[{"name":"Xarelto","share_pct":57.9},{"name":"Eliquis","share_pct":42.1}],"max_beneficiaries":24},{"class":"Low Molecular Weight Heparin","setting":"prescribed","share_pct":7.7,"drugs":[{"name":"Enoxaparin Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":19.3,"classes_total":1,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":14}]},{"area":"Metabolism & gastrointestinal","share_pct":8.7,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":5,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null},{"class":"Amino Acid","setting":"prescribed","share_pct":3.7,"drugs":[{"name":"Endari","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":6,"facility_pct":94},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Guidelines Can Be Lifesaving: The Vermont Model of Thromboprophylaxis Implementation","year":2026,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op-26-00262","status":"verified"},{"title":"Arterial and venous thromboembolism in hospitalized patients with COVID-19: a national multicenter cohort study","year":2026,"journal":"Blood Vessels Thrombosis & Hemostasis","source_url":"https://doi.org/10.1016/j.bvth.2026.100173","status":"verified"},{"title":"Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis","year":2026,"journal":"Blood Vessels Thrombosis & Hemostasis","source_url":"https://doi.org/10.1016/j.bvth.2026.100197","status":"verified"},{"title":"OC 20.3 Patients Educating Patients: A Scalable Patient-Led Webinar Model Integrating Patient and Clinician Expertise in Venous Thromboembolism Care","year":2026,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2026.103561","status":"verified"},{"title":"Patient-centered management of heavy menstrual bleeding while on anticoagulation: A survey study","year":2025,"journal":"European Journal of Obstetrics & Gynecology and Reproductive Biology","source_url":"https://doi.org/10.1016/j.ejogrb.2025.114650","status":"verified"}],"source":"works"},"similar":[{"name":"Steven Nissen","slug":"steven-nissen","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/steven-nissen","json_url":"https://www.findmykol.com/kol/steven-nissen/profile.json"},{"name":"Samir Kapadia","slug":"samir-kapadia","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/samir-kapadia","json_url":"https://www.findmykol.com/kol/samir-kapadia/profile.json"},{"name":"Mina Chung","slug":"mina-chung","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mina-chung","json_url":"https://www.findmykol.com/kol/mina-chung/profile.json"},{"name":"Serpil Erzurum","slug":"serpil-erzurum","institution":"Cleveland Clinic","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/serpil-erzurum","json_url":"https://www.findmykol.com/kol/serpil-erzurum/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}